These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103 [TBL] [Abstract][Full Text] [Related]
8. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093 [TBL] [Abstract][Full Text] [Related]
9. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Brown LA; Nunez DJ; Brookes CI; Wilkins MR Cardiovasc Res; 1995 Jun; 29(6):768-74. PubMed ID: 7656280 [TBL] [Abstract][Full Text] [Related]
10. [Contribution of endothelin and its receptors to ouabain-induced hypertension in rats]. Jiang X; Guo N; Lü ZR Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1297-300. PubMed ID: 16982439 [TBL] [Abstract][Full Text] [Related]
11. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225 [TBL] [Abstract][Full Text] [Related]
13. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. Adamczak M; Gross ML; Amann K; Ritz E J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423 [TBL] [Abstract][Full Text] [Related]
15. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Amann K; Koch A; Hofstetter J; Gross ML; Haas C; Orth SR; Ehmke H; Rump LC; Ritz E Kidney Int; 2001 Oct; 60(4):1309-23. PubMed ID: 11576345 [TBL] [Abstract][Full Text] [Related]
17. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Hu P; Qin YH; Pei J; Lei FY; Hu B; Lu L Exp Mol Pathol; 2010 Aug; 89(1):51-7. PubMed ID: 20493835 [TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034 [TBL] [Abstract][Full Text] [Related]
20. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Schwarz U; Amann K; Orth SR; Simonaviciene A; Wessels S; Ritz E Kidney Int; 1998 Jun; 53(6):1696-705. PubMed ID: 9607202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]